Latest Interviews
Showing 166–180 of 272 transcripts.
Clear all filters- Goldman Sachs7 min
Accelerated Innovation in the Healthcare Industry
Driven by unprecedented government-industry collaboration and $3 billion in BARDA funding, the medical sector is compressing vaccine development timelines from four years to eighteen months while restructuring healthcare delivery through permanent telemedicine and domestic supply chain priorities. Concurrently, plummeting genome sequencing costs are accelerating research into gene and cell therapies for rare diseases, while robotic surgery adoption enhances ICU surge capacity and patient recovery rates. This convergence of policy support, financial investment, and technological integration has created the most favorable investment environment in history, signaling a decade-long trajectory of rapid innovation in genomics and next-generation medicine.
- Goldman Sachs8 min
The Evolution of Europe’s Tech Landscape
European technology companies have leveraged robust pre-existing infrastructure to maintain business continuity while accelerating market trends like e-commerce adoption and digital collaboration tools. This sector is simultaneously experiencing a surge in private unicorns and capital availability driven by returning executives and a shift toward ambitious global valuations. Although currently underweighted in public markets compared to the U.S., a wave of high-profile listings and deal activity across defensive, opportunistic, and strategic phases signals a maturing ecosystem.
- Goldman Sachs10 min
The Outlook for the Corporate Credit Default Cycle
Goldman Sachs identified three sequential credit risks in early March, noting that Federal Reserve intervention in late March successfully mitigated the most severe credit crunch and liquidity impairment while leaving fundamental financial distress intact. Although the central bank's announcement triggered an 85% surge in primary market issuance and normalized secondary trading conditions, the firm maintains a 13% default rate forecast for the year due to persistent earnings pressure on lower-rated issuers. Market participants anticipate a strategic shift toward restructurings rather than liquidations, with a projected sector rotation back into cyclical industries like energy as the economic recovery progresses.
- Goldman Sachs21 min
Daniel Susskind, Author of "A World Without Work"
Economist Daniel Susskind argues that the 21st century faces a crisis of scarcity for well-paid work driven by technology rather than a lack of tasks, creating distinct challenges in inequality, concentrated power, and the erosion of meaning derived from employment. While dismissing Malthusian pessimism, Susskind predicts that technological expansion will eventually double global GDP per capita within decades, prompting a necessary policy shift from traditional labor market regulation to "leisure policies" and the rapid adoption of Universal Basic Income to address the immediate collapse in demand exacerbated by the pandemic. To navigate this transition, he advises young professionals to either cultivate non-routine interpersonal skills that resist automation or acquire technical expertise to design automated systems, warning that current educational models remain dangerously misaligned with future economic realities.
- Goldman Sachs1h 1m
Phasing in the Reopening of the Economy
Sharmin Mossavar-Rahmani, Dr. Luciana Borio, Dr. Florian Krammer, Sharmeen Mosavaramani
As of April 2020, global infections surpassed 3.2 million with 61,600 U.S. fatalities, prompting a complex transition toward economic reopening despite many states failing to meet sustained case reduction criteria. Therapeutic advancements, notably the NIH's findings on baricitinib, offer potential mortality reductions while experimental monoclonal antibodies and multiple vaccine platforms aim for deployment by mid-year to address the pathogen's persistence. Public health officials warn that premature relaxation of restrictions risks autumnal resurgence, necessitating robust testing expansion and contact tracing to manage recurring waves until herd immunity is achieved.
- Goldman Sachs57 min
The State of the Real Estate Market
Sharmin Mossavar-Rahmani, Alan Kava, Roy March, Ralph Rosenberg, Sharmeen Mosavaramani
On April 24, 2020, Goldman Sachs, KKR, and Eastdale executives analyzed a global real estate market defined by record cap rate spreads, an 80% drop in private transaction volumes, and divergent sector performance driven by the COVID-19 pandemic. While hospitality and retail faced existential threats from plummeting occupancy and accelerating structural decline, industrial and life science sectors demonstrated resilience through e-commerce growth and near-perfect rent collections. Industry leaders anticipate a prolonged recovery period where well-capitalized banks may stabilize the market, yet a sharp bifurcation remains between distressed "have-to" sellers and liquidity-rich investors poised to acquire depressed assets.
- Goldman Sachs42 min
Jeff Maggioncalda, CEO of Coursera
Jeff Maggioncalda, Catherine Tate
Coursera leverages its ecosystem of 55 million learners, 165 elite universities, and 40 industry partners to rapidly expand access during the 2020 pandemic, seeing a twelve-fold surge in new learner acquisition and a five- to eighteen-fold spike in demand across diverse domains. CEO Jeff Maggioncalda highlights a structural transformation where 50 universities transitioned to the "Coursera for Campus" model within months, driving over 5.9 million total enrollments and prompting a permanent shift toward blended learning and credentialing as a standard business continuity strategy. This growth is underpinned by innovations like the "Course Match" algorithm and a freemium funnel that reduces student acquisition costs to $1,250, positioning online degrees and corporate deep-skilling tracks as essential solutions for a global higher education landscape facing significant infrastructure disparities.
- Goldman Sachs44 min
Adm. Timothy J. Keating, USN (Ret.) and Brig. Gen. Robert S. Spalding III, USAF (Ret.)
Timothy J. Keating, Robert S. Spalding III, Admiral Timothy Keating, Brigadier General Robert S. Spalding III, Norman Nye, Tim Keating, Rob Spalding
Hosted by Goldman Sachs's Norman Nye on April 15, 2020, Admiral Timothy Keating and Brigadier General Rob Spalding assessed how the COVID-19 pandemic accelerated U.S.-China geopolitical rivalry, particularly regarding Taiwan, supply chain decoupling, and 5G surveillance infrastructure. The experts concluded that the crisis would permanently shift global alignment toward a "democratic bloc" prioritizing national security over economic integration, forcing a reshoring of critical industries and tighter restrictions on Chinese technology. They further warned that economic strains could provoke China to employ gray zone tactics while the United States pivots toward strengthening alliances in the Indo-Pacific, India, and Latin America.
- Goldman Sachs1h 2m
An Update on Therapies and Vaccines
Sharmin Mossavar-Rahmani, Dr. Richard Hatchett, Esther Krofah, Dr. Paul Stoffels
On April 14, 2020, Goldman Sachs CIO Wealth Management hosted Sharmin Mosavar-Rahmani for the eighth iteration of a COVID-19 series discussing the epidemiological landscape of nearly 2 million infections and 110,000 fatalities. Experts outlined a pipeline where effective therapies are expected within four to six months while vaccines leveraging platforms from CEPI and Johnson & Johnson may require 12 to 18 months, with potential emergency use by the first quarter of 2021. The call further detailed critical challenges regarding antibody test accuracy, the certainty of a second wave, and the necessity for aggressive surveillance and testing infrastructure to facilitate any safe economic reopening.
- Goldman Sachs20 min
Jovita Carranza, Administrator of the U.S. Small Business Administration
Jovita Carranza, David Solomon
On April 9, 2020, Goldman Sachs Chairman David Solomon and SBA Administrator Jovita Carranza hosted a call to outline the Paycheck Protection Program's expanded capacity, which now involves over 4,100 lenders and a $349 billion funding pool. The administration detailed critical loan mechanics, including a 1% fixed interest rate, a June 30 application deadline, and specific forgiveness rules tied to payroll and utility expenses. Carranza further advised small businesses on utilizing the SBA's new "Find a Lender" tool while addressing the urgent need for expedited permits to support essential goods production.
- Goldman Sachs53 min
The CARES Act and its Impact on the US Economic Outlook
Sharmin Mossavar-Rahmani, Alec Phillips, Jan Hatzius, William G. Gale, Sharmeen Mosavar-Rahmani, Bill Gale
On March 31, 2020, Goldman Sachs hosted a client call featuring Chief Economist Jan Hatzius and external fiscal experts to analyze the CARES Act and downgrade the 2020 U.S. economic outlook to a record contraction. The discussion detailed the legislation's targeted relief components, including expanded unemployment benefits, direct stimulus checks, and $46 billion in aid for the airline industry, alongside projections that Q2 GDP will fall approximately 10% with net debt-to-GDP rising above 100%. Despite these severe short-term headwinds, experts concluded that low interest rates and the Federal Reserve's potential $4.5 trillion lending capacity would likely prevent a sovereign debt crisis.
- Goldman Sachs40 min
US Senators Marco Rubio and Ben Cardin
Marco Rubio, Ben Cardin, David Solomon
Hosted by Goldman Sachs Chairman David Solomon on March 30, 2020, Senators Marco Rubio and Ben Cardin outlined critical CARES Act provisions to address the 96% of small businesses already impacted by the COVID-19 crisis. The discussion detailed the Paycheck Protection Program's 100% federal guarantee and loan forgiveness terms alongside emergency grants and tax credits designed to sustain payroll and operations for entities with 500 employees or fewer. While emphasizing rapid fund distribution through over 800 authorized lenders, the committee also cautioned against fraudulent schemes and anticipated further legislative action should the economic downturn extend beyond the initial 60 to 90-day window.
- Goldman Sachs58 min
An Update on the Economic and Public Health Implications of Coronavirus for Europe
Sharmin Mossavar-Rahmani, Dr. David Heymann, Sven Jari Stehn, Silvia Ardagna, Peter Oppenheimer, Sharmeen Mosavar-Rahmani
Hosted by Goldman Sachs on March 26, 2020, a panel of infectious disease experts and economists analyzed the severe impact of the coronavirus on Europe, highlighting Italy's high mortality due to demographic factors and early hospital overload while noting a potential 9% GDP contraction in the Euro area by year-end. In response to the crisis, European central banks and governments deployed unprecedented monetary and fiscal measures, including unlimited asset purchases and corporate loan guarantees, though fragmentation within the Eurozone contrasted with more coordinated US actions. Despite the deepening economic downturn, equity strategists noted that market valuations have reached historic lows, projecting a high probability of double-digit returns over the subsequent 24 months as earnings decline stabilizes.
- Goldman Sachs1h 22m
A Coronavirus Update with Leading Health Experts and Business Leaders
Sharmin Mossavar-Rahmani, Dr. Thomas Schinecker, Steve Rusckowski, Dr. Leonard Schleifer, Stéphane Bancel, Pablo Tebas, Peter Slavin, Dr. Barry Bloom, Sharmeen Mosavar-Rahmani
Hosted by Goldman Sachs on March 20, 2020, industry leaders including Regeneron's Dr. Leonard Schleifer, Moderna's Stefan Bancel, and Quest Diagnostics executives detailed rapid advancements in diagnostic scaling, therapeutic trials, and vaccine development. The panel highlighted that while testing capacity is projected to meet demand within weeks, critical bottlenecks in PPE and supply chains persist, prompting urgent calls for Defense Production Act mobilization to protect healthcare workers. Simultaneously, experts outlined aggressive timelines for Moderna's mRNA vaccine reaching healthcare workers by late 2020 and emphasized that sustainable economic recovery relies on serologic testing and strict social distancing to prevent a predicted second wave.
- Goldman Sachs1h 4m
Dr. Michael Mina of the Harvard T.H. Chan School of Public Health
Michael Mina, Salveen Richter, Terence Flynn, Solving Richter
Dr. Mina outlines the novel coronavirus as a highly transmissible pathogen with reduced virulence that threatens global pandemic spread through widespread asymptomatic transmission and unstable immunity patterns. Current U.S. diagnostics face critical supply chain bottlenecks that necessitate triage-based testing, while therapeutic strategies rely on supportive care and experimental antivirals like Remdesivir alongside accelerating vaccine development. The speaker predicts that aggressive social distancing can suppress transmission to protect healthcare capacity, though long-term management will likely require balancing economic needs with endemic cycles rather than aiming for total eradication.